Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Vtx-002
2. 2097854-81-2
3. Vtx002
4. Opl-002
5. K02shw3kv9
6. Refchem:1099390
7. (5r)-5-[2,5-dichloro-4-[5-[8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-1,2,4-oxadiazol-3-yl]phenoxy]piperidin-2-one
8. Tamuzimod [inn]
9. Tamuzimod (usan/inn)
10. Tamuzimod [usan]
11. Orb1982659
12. Chembl5314488
13. Schembl18869627
14. Schembl30275258
15. Hnrwgydmtrplcq-snvbaglbsa-n
16. Glxc-27924
17. Da-78185
18. Hy-148801
19. Cs-0641186
20. D12897
21. (5r)-5-(2,5-dichloro-4-{5-[8-chloro-6- (trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-1,2,4- Oxadiazol-3-yl}phenoxy)piperidin-2-one
22. 2-piperidinone, 5-[2,5-dichloro-4-[5-[8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-1,2,4-oxadiazol-3-yl]phenoxy]-
| Molecular Weight | 546.7 g/mol |
|---|---|
| Molecular Formula | C21H13Cl3F3N5O3 |
| XLogP3 | 5.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 4 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 94.6 |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 786 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE